Natpara (parathyroid hormone analog) — United Healthcare

Initial criteria

• Diagnosis of hypocalcemia resulting from chronic hypoparathyroidism
• Patient is currently on adequate supplemental calcium and active vitamin D (e.g., calcitriol) therapy as evidenced by serum calcium (albumin corrected) > 7.5 mg/dL
• Prescribed by an Endocrinologist OR Nephrologist

Reauthorization criteria

• Documentation of positive clinical response (e.g., total serum calcium level (albumin corrected) within the lower half of the normal range (approximately 8 to 8.5 mg/dL))
• Patient continues to take concomitant calcium supplementation that is sufficient to meet daily requirements
• Prescribed by an Endocrinologist OR Nephrologist

Approval duration

12 months